Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:34 AM
Ignite Modification Date:
2025-12-25 @ 1:34 AM
NCT ID:
NCT01425294
Eligibility Criteria:
Inclusion Criteria:
* Chinese postmenopausal women with estrogen receptor positive, locally advanced or metastatic breast cancer Failure to previous anti-estrogen therapy, already received Faslodex 250mg treatment as determined by treating physician.
* The prescription of the Faslodex is clearly separated from the decision to include the subject in the NIS, and is part of normal medical practice. The recruitment of the patient to the study should be within 1 month of the first Faslodex injection.
* Provision of subject informed consent.
Exclusion Criteria:
* If participating in any controlled clinical trial, the subject cannot take part in this study.
* Hypersensitivity to the active substance, or to any of the other excipients.
* Pregnancy and lactation, or severe hepatic impairment.
Healthy Volunteers:
False
Sex:
FEMALE
Study:
NCT01425294
Study Brief:
Protocol Section:
NCT01425294